Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
94.78 USD88.59 USD111.08 USD
+45.94%
88.59 USDCurrent price is 45.9% above the base model value.
G
HealthcareDrug Manufacturers - GeneralUnited States
GILD.US · Gilead Sciences, Inc.
NMS · US · USD
Latest price129.29 USD
30D+10.83%
Vs. base value+45.9%
Research summary
GILD.US latest organized financial period shows revenue lacks a complete YoY comparison and net income grew +1,673% YoY. Current price is about 129 USD, while the model base case is about 88.59 USD; the current price sits +45.9% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue-
Net income9B USD
Free cash flow9B USD
Operating cash flow10B USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:21
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price129.29 USD
Base value88.59 USD
Vs. base+45.9%
Price date2026/04/28
94.78 USD88.59 USD111.08 USD
+45.94%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
95.71 USD154.85 USD201.77 USD
-16.51%
154.85 USDCurrent price is 16.5% below the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth3.0%
Current price implies roughly 3.0% annualized FCF growth.
3.0%Current price implies roughly 3.0% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
44.96 USD44.96 USD44.96 USD
+188%
44.96 USDCurrent price is 187.5% above the base model value.
Updated: 2026/04/29 07:21
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 10
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | - | 9B USD | 9B USD | 6.78 |
| 2024/12/30 | Annual | - | 480M USD | 10B USD | 0.38 |
| 2023/12/30 | Annual | - | 6B USD | 7B USD | 4.5 |
| 2022/12/30 | Annual | - | 5B USD | 8B USD | 3.64 |
| 2021/12/30 | Annual | - | 6B USD | 11B USD | 4.93 |
Ad placement